Genomic landscape of clinically acquired resistance alterations in patients treated with KRASG12C inhibitorsJakob M. Riedl, Ryan B. Corcoran, Ferran Fece de la Cruz et al.|Annals of Oncology|2025Cited by 49
TOP1 Mutations and Cross-Resistance to Antibody–Drug Conjugates in Patients with Metastatic Breast CancerRachel O. Abelman, Aditya Bardia, Bryanna L. Norden et al.|Clinical Cancer Research|2025Cited by 39